MIA as a reliable tumor marker in the serum of patients with malignant melanoma

Anticancer Research

Volumn 20, Issue 6 D, 2000, Pages 5041-5044

  Stahlecker, J ^a   Gauger, A ^a   Bosserhoff, A ^a   Buttner R ^a   Ring, J ^a   Hein, R ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Malignant melanoma; Metastases; MIA (melanoma inhibiting activity); Tumor marker

Indexed keywords

ANTINEOPLASTIC AGENT; MELANOMA INHIBITING ACTIVITY; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ANTIGEN DETECTION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CONFERENCE PAPER; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034450654     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Das zentralregister des malignen melanoms der deutschen dermatologischen gesellschaft in den Jahren 1983-1993. Epidemiologische entwicklungen und aktuelle therapeutische versorgung des malignen melanoms der haut
2. Cutaneous malignant melanoma
3. Dysplastic melanocytic nevi and cutaneous melanoma: Markers of increased risk for affected persons and blood relatives
4. Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: Multicenter case-control study of central malignant melanoma registry of the german Dermatological Society
5. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects
6. Diagnostische und therapeutische standards in der dermatologischen onkologie
7. Prognosis in cutaneous melanoma: Tumor thickness as a guide to treatment
8. Autocrine tumor cell inhibiting activities from human malignant melanoma
9. Purification and analysis of growth regulating proteins secreted by a human melanoma cell line
10. Cloning of a novel malignant melanoma-derived growth regulatory protein, MIA
11. Structure and promoter analysis of the gene encoding the human melanoma-inhibiting protein, MIA
12. Cloning of a retionic acid-sensitive mRNA expressed in cartilage and during chondrogenesis
13. The mouse MIA/CD-RAP gene: Structure, chromosomal localization and expression in cartilage and chondrosarcoma
14. Melanoma-inhibiting activity, a novel serum marker for progression of malignant melanoma
15. Measurements of tumor thickness
16. Stellungnahme und empfehlungen der komission malignes melanom der deutschen dermatologischen gesellschaft zur diagnostik, behandlung und nachsorge des malignen melanoms der haut-stand